
Sign up to save your podcasts
Or


Eduardo Bravo, CEO of Citryll, shares his insights about leadership in biopharma and how Citryll is working to transform the approach to treating immune mediated inflammatory diseases.
By John Simboli5
77 ratings
Eduardo Bravo, CEO of Citryll, shares his insights about leadership in biopharma and how Citryll is working to transform the approach to treating immune mediated inflammatory diseases.

534 Listeners

3,072 Listeners

1,091 Listeners

940 Listeners

795 Listeners

125 Listeners

322 Listeners

96 Listeners

9,942 Listeners

34 Listeners

519 Listeners

146 Listeners

349 Listeners

182 Listeners

467 Listeners